Trial intelligence / Profile preview

Effect of remimazolam vs propofol on left heart function during anesthesia induction in elderly patients

ChiCTR2200059697Phase 4Not yet recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in None comparing Propofol group with Remimazolam group (2 arms). Primary endpoints: Left ventricular ejection fraction (LVEF), Stroke volume (SV) and 5 more. Planned start May 2022; status: not yet recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2200059697.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200059697.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call